Loading...
XASXRSH
Market cap61mUSD
Jan 07, Last price  
0.07AUD
1D
-8.64%
1Q
64.44%
Name

Respiri Ltd

Chart & Performance

D1W1MN
XASX:RSH chart
P/E
—
P/S
214.84
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
15.31%
Rev. gr., 5y
-14.94%
Revenues
457k
+547.80%
51,91133,571325,944100,191225,432348,493332,08712,96810,85918,97593,988677,755825,603861,4551,026,2522,155,307270,074253,68870,533456,914
Net income
-7m
L+23.44%
-724,190-1,227,244-5,127,136-11,678,053-6,701,092-5,939,761-6,677,311-5,585,172-5,583,649-10,309,957-5,464,443-4,010,944-2,522,052-3,207,220-8,474,586-7,260,935-11,040,347-6,624,313-5,775,290-7,129,247
CFO
-7m
L+47.91%
-798,419-656,614-2,288,184-5,800,146-3,495,817-5,121,535-5,353,963-4,879,977-4,935,301-9,098,240-5,891,940-2,389,299-2,927,424-2,077,008-6,411,324-4,687,956-7,339,097-8,477,582-4,490,186-6,641,350
Earnings
Feb 26, 2025

Profile

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
URL
http://respiri.com.au/
IPO date
Jul 14, 2000
Employees
2
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
457
547.80%
71
-72.20%
254
-6.07%
Cost of revenue
7,083
4,451
5,679
Unusual Expense (Income)
NOPBT
(6,626)
(4,380)
(5,425)
NOPBT Margin
Operating Taxes
(3)
(551)
(497)
Tax Rate
NOPAT
(6,626)
(3,830)
(4,928)
Net income
(7,129)
23.44%
(5,775)
-12.82%
(6,624)
-40.00%
Dividends
Dividend yield
Proceeds from repurchase of equity
8,249
2,868
1,606
BB yield
-31.18%
-9.36%
-4.01%
Debt
Debt current
1,236
33
71
Long-term debt
174
233
71
Deferred revenue
Other long-term liabilities
70
Net debt
618
119
(1,076)
Cash flow
Cash from operating activities
(6,641)
(4,490)
(8,478)
CAPEX
(22)
(2)
Cash from investing activities
(1,887)
(22)
(2)
Cash from financing activities
9,129
3,459
1,639
FCF
(6,966)
(2,798)
(6,627)
Balance
Cash
791
146
1,217
Long term investments
Excess cash
769
143
1,205
Stockholders' equity
2,637
827
3,008
Invested Capital
3,232
833
1,874
ROIC
ROCE
EV
Common stock shares outstanding
1,017,631
806,455
728,628
Price
0.03
-31.58%
0.04
-30.91%
0.06
-17.91%
Market cap
26,458
-13.66%
30,645
-23.53%
40,075
-14.44%
EV
27,076
30,765
38,999
EBITDA
(6,562)
(4,303)
(5,343)
EV/EBITDA
Interest
65
15
Interest/NOPBT